Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

EIDX

Eidos Therapeutics (EIDX)

Eidos Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:EIDX
日付受信時刻ニュースソース見出しコード企業名
2021/02/0606 : 32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2820 : 05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2706 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2623 : 01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2622 : 48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2622 : 47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2622 : 30GlobeNewswire Inc.BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2106 : 23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/2006 : 01GlobeNewswire Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera...NASDAQ:EIDXEidos Therapeutics Inc
2021/01/1606 : 06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/1406 : 50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/1406 : 30GlobeNewswire Inc.BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for MergerNASDAQ:EIDXEidos Therapeutics Inc
2021/01/1221 : 43Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/1221 : 32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/1221 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/0806 : 02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/0506 : 31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2021/01/0421 : 30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr...NASDAQ:EIDXEidos Therapeutics Inc
2020/12/2921 : 31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2020/12/2906 : 31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2020/12/1523 : 31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:EIDXEidos Therapeutics Inc
2020/12/0507 : 35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2020/11/1407 : 01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2020/11/1106 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2020/11/0521 : 30GlobeNewswire Inc.BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
2020/11/0306 : 02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
2020/10/3105 : 56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
2020/10/3005 : 48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIDXEidos Therapeutics Inc
2020/10/3005 : 31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
2020/10/3005 : 30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EIDX

最近閲覧した銘柄

Delayed Upgrade Clock